Velano Vascular Receives Additional FDA Clearance for Innovative Blood Draw Device

SAN FRANCISCO, Jan. 27, 2016 /PRNewswire/ -- Velano Vascular, a medical technology company transforming and enhancing the care experience for hospitalized patients and their practitioners, announced today that the company received U.S. Food and Drug Administration (FDA) clearance for a modified version of its novel, needle-free blood draw device. The Velano device is designed to reduce blood draw-related discomfort and anxiety for hospital inpatients, provide a safer work environment for healthcare providers, and standardize today's fragmented approaches to inpatient blood draws.

Read the press release at PR Newswire